// App-Quantinova.ai

4874 : Interleukin-12/FasTI: A novel bi-functional fusion protein for cancer immunotherapy

Researchers

Presenter

  • Xi Yang

Principal Investigators

  • Ashlee Tietje

  • Xianzhong Yu

  • Yanzhang Wei

Medical Centers

  • Clemson University, Clemson, SC

  • Southern Wesleyan University, Central, SC.

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Lung Cancer

  • Solid malignancies

Biomarkers

  • Natural Killer cells

  • Interleukin 12

Drug/Treatment

  • IL-12

  • IFN-lambda

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved